comparemela.com

Latest Breaking News On - Division of hepatology - Page 1 : comparemela.com

DURECT Corporation (NASDAQ:DRRX) Q1 2023 Earnings Call Transcript

Operator: Greetings and welcome to the DURECT Corporation First Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.

Albireo Pharma, Inc : Italian Medicines Agency Approves Reimbursed Access to Bylvay (odevixibat) For Patients with All PFIC Types

Positive Agenzia Italiana del Farmaco (AIFA) decision provides reimbursed access to the first medicine available for the treatment of all types of PFIC, a rare and devastating disorder that affects

vimarsana © 2020. All Rights Reserved.